Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

New clinical scoring system for prognosis of early recurrence of colorectal liver metastases after surgical treatment

S. Alan, L. Vaclav, P. Martin, T. Vladislav, T. Ondrej, S. Tomas, K. Stanislav, L. Holubec

. 2011 ; 58 (109) : 1286-1290.

Language English Country Greece

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NS10230 MZ0 CEP Register

BACKGROUND/AIMS: To determine the relationship between the mRNA expression of MMP-2, MMP-9, TIMP-1, TIMP-2 and CEA in tumour tissue and preoperative serum levels of these tumour markers in patients with colorectal liver metastases (CLM). Additionally, to establish a new scoring system based upon these results in combination with the volume of the metastatic process to identify patients with a high risk of early recurrence of CLM. METHODOLOGY: The correlation between the mRNA expression of CEA, TIMP-1, TIMP-2, MMP-2 and MMP-9 in tissue samples and preoperative serum levels of the named tumour markers was performed on 27 patients. The scoring system was proposed as a combination of all the independent parameters (mRNA expression of TIMP-1, MMP-9 and CEA in tumour tissue samples and preoperative serum levels of CEA and TIMP-1) in combination with the volume of the metastatic process. The evaluation was conducted in relation to the disease free interval (DFI). RESULTS: We observed a statistically significant relationship between the volume of liver metastases and DFI (p<0.0337). The scoring system divided the patients into groups with a tendency of early recurrence (p<0.0126). CONCLUSIONS: The high stages in our scoring systems augment the risk of recurrence. The proposed scoring system was shown to be an efficient instrument helpful in complex surgical and oncological access to patients after radical surgical treatment of CLM.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022299
003      
CZ-PrNML
005      
20170407134442.0
007      
ta
008      
120806s2011 gr f 000 0#eng||
009      
AR
024    7_
$a 10.5754/hge10045 $2 doi
035    __
$a (PubMed)21937396
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Sutnar, Alan $7 xx0081862 $u Department of Surgery, Charles University, Prague, Czech Republic.
245    10
$a New clinical scoring system for prognosis of early recurrence of colorectal liver metastases after surgical treatment / $c S. Alan, L. Vaclav, P. Martin, T. Vladislav, T. Ondrej, S. Tomas, K. Stanislav, L. Holubec
520    9_
$a BACKGROUND/AIMS: To determine the relationship between the mRNA expression of MMP-2, MMP-9, TIMP-1, TIMP-2 and CEA in tumour tissue and preoperative serum levels of these tumour markers in patients with colorectal liver metastases (CLM). Additionally, to establish a new scoring system based upon these results in combination with the volume of the metastatic process to identify patients with a high risk of early recurrence of CLM. METHODOLOGY: The correlation between the mRNA expression of CEA, TIMP-1, TIMP-2, MMP-2 and MMP-9 in tissue samples and preoperative serum levels of the named tumour markers was performed on 27 patients. The scoring system was proposed as a combination of all the independent parameters (mRNA expression of TIMP-1, MMP-9 and CEA in tumour tissue samples and preoperative serum levels of CEA and TIMP-1) in combination with the volume of the metastatic process. The evaluation was conducted in relation to the disease free interval (DFI). RESULTS: We observed a statistically significant relationship between the volume of liver metastases and DFI (p<0.0337). The scoring system divided the patients into groups with a tendency of early recurrence (p<0.0126). CONCLUSIONS: The high stages in our scoring systems augment the risk of recurrence. The proposed scoring system was shown to be an efficient instrument helpful in complex surgical and oncological access to patients after radical surgical treatment of CLM.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a karcinoembryonální antigen $x genetika $7 D002272
650    _2
$a kolorektální nádory $x patologie $7 D015179
650    _2
$a lidé $7 D006801
650    _2
$a nádory jater $x metabolismus $x mortalita $x sekundární $x chirurgie $7 D008113
650    _2
$a matrixová metaloproteinasa 2 $x genetika $7 D020778
650    _2
$a matrixová metaloproteinasa 9 $x genetika $7 D020780
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a messenger RNA $x analýza $7 D012333
650    _2
$a recidiva $7 D012008
650    _2
$a tkáňový inhibitor metaloproteinasy 1 $x genetika $7 D019715
650    _2
$a tkáňový inhibitor metaloproteinasy 2 $x genetika $7 D019716
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Liška, Václav, $d 1978- $7 xx0073943
700    1_
$a Pešta, Martin, $d 1976- $7 xx0073915
700    1_
$a Třeška, Vladislav, $d 1957- $7 jn20000402436
700    1_
$a Topolčan, Ondřej, $d 1943- $7 jn20000402383
700    1_
$a Skalický, Tomáš, $d 1965- $7 xx0017169
700    1_
$a Kormunda, Stanislav $7 xx0103970
700    1_
$a Holubec, Luboš, $d 1941- $7 skuk0003095
773    0_
$w MED00002025 $t Hepato-gastroenterology $x 0172-6390 $g Roč. 58, č. 109 (2011), s. 1286-1290
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21937396 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120806 $b ABA008
991    __
$a 20170407134736 $b ABA008
999    __
$a ok $b bmc $g 944212 $s 779596
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 58 $c 109 $d 1286-1290 $i 0172-6390 $m Hepato-gastroenterology $n Hepatogastroenterology $x MED00002025
GRA    __
$a NS10230 $p MZ0
LZP    __
$b NLK111 $a Pubmed-20120806/12/01

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...